- Home
- FMS vs FROG Comparison
FMS vs FROG Comparison
Compare FMS & FROG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMS | FROG |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 11.6B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FMS | FROG |
|---|---|---|
| Price | $21.99 | $90.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 23 |
| Target Price | $23.92 | ★ $112.23 |
| AVG Volume (30 Days) | 945.1K | ★ 1.6M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.73% | N/A |
| EPS Growth | N/A | ★ 1.59 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $531,840,000.00 |
| Revenue This Year | N/A | $22.35 |
| Revenue Next Year | $3.27 | $17.98 |
| P/E Ratio | $15.62 | ★ N/A |
| Revenue Growth | N/A | ★ 24.12 |
| 52 Week Low | $20.02 | $34.05 |
| 52 Week High | $27.40 | $105.76 |
Technical Indicators
Market Signals| Indicator | FMS | FROG |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 47.98 |
| Support Level | $20.27 | $84.25 |
| Resistance Level | $23.03 | $98.17 |
| Average True Range (ATR) | 0.44 | 5.47 |
| MACD | 0.07 | -1.00 |
| Stochastic Oscillator | 68.98 | 41.35 |
Price Performance
Historical ComparisonAbout FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from united states and also has its presence in Israel, India and other regions.